Biblio
Export 11 results:
Author Title Type [ Year] Filters: Author is Schneider, Julie A [Clear All Filters]
“Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.”, J Alzheimers Dis, vol. 96, no. 2, pp. 683-693, 2023.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
, “Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
, “Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility.”, J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
, “MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 83, no. 2, pp. 683-692, 2021.
, “Association of Low Systolic Blood Pressure with Postmortem Amyloid-β and Tau.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1755-1764, 2020.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “Religious Orders Study and Rush Memory and Aging Project.”, J Alzheimers Dis, vol. 64, no. s1, pp. S161-S189, 2018.
, “Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1485-1493, 2017.
, “Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.”, J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
, “National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.”, Alzheimers Dement, vol. 8, no. 1, pp. 1-13, 2012.
,